VEEV
Veeva Systems Inc
$
286.900
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
290.4299
Open
287.270
VWAP
287.20
Vol
1.46M
Mkt Cap
46.88B
Low
284.000
Amount
418.40M
EV/EBITDA(TTM)
49.43
Total Shares
161.65M
EV
40.87B
EV/OCF(TTM)
33.95
P/S(TTM)
16.65
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. It offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and the strategic business functions from research and development (R&D) through commercialization. Its four product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes, and partners across content management, training, quality management, assurance, and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Veeva Data Cloud is a data platform comprised of connected reference data, deep data, and transaction data.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q4
FY2026Q3
FY2026Q2
793.34M
+10.05%
1.900
+9.21%
778.59M
+11.35%
1.889
+7.96%
768.49M
+13.65%
1.899
+17.22%
Estimates Revision
The market is revising Upward the revenue expectations for Veeva Systems Inc. (VEEV) for FY2026, with the revenue forecasts being adjusted by 1.73% over the past three months. During the same period, the stock price has changed by 23.63%.
Revenue Estimates for FY2026
Revise Upward
+1.73%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward
+4.99%
In Past 3 Month
Stock Price
Go Up
+23.63%
In Past 3 Month
23 Analyst Rating
3.00% Upside
Wall Street analysts forecast VEEV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VEEV is 295.52 USD with a low forecast of 210.00 USD and a high forecast of 335.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Buy
8 Hold
1 Sell
Moderate Buy
3.00% Upside
Current: 286.900
Low
210.00
Averages
295.52
High
335.00
3.00% Upside
Current: 286.900
Low
210.00
Averages
295.52
High
335.00
Mizuho
Outperform
maintain
$280 -> $295
2025-06-02
Reason
Mizuho
Price Target
$280 -> $295
2025-06-02
maintain
Outperform
Reason
Mizuho raised the firm's price target on Veeva to $295 from $280 and keeps an Outperform rating on the shares following the fiscal Q1 report. The firm increased estimates to reflect to reflect the company's better sales momentum in both Commercial Cloud and Development Cloud.
Citi
Tyler Radke
Buy
upgrade
$265 -> $329
2025-05-30
Reason
Citi
Tyler Radke
Price Target
$265 -> $329
2025-05-30
upgrade
Buy
Reason
Citi analyst Tyler Radke raised the firm's price target on Veeva to $329 from $265 and keeps a Buy rating on the shares. Veeva delivered one of their strongest quarterly beats in recent memory, the analyst tells investors in a research note. The firm says the company's commercial strength shows "plenty of growth ahead."
Barclays
Overweight
maintain
$285 -> $300
2025-05-29
Reason
Barclays
Price Target
$285 -> $300
2025-05-29
maintain
Overweight
Reason
Barclays raised the firm's price target on Veeva to $300 from $285 and keeps an Overweight rating on the shares. The company reported better than expected Q1 billings of $714M, driven by outperformance in Crossix, the analyst tells investors in a research note. The firm says Veeva's guidance is going up across the board, and there was no change in macro assumptions.
Piper Sandler
Brent Bracelin
Overweight
maintain
$255 -> $325
2025-05-29
Reason
Piper Sandler
Brent Bracelin
Price Target
$255 -> $325
2025-05-29
maintain
Overweight
Reason
Piper Sandler analyst Brent Bracelin raised the firm's price target on Veeva to $325 from $255 and keeps an Overweight rating on the shares. The acceleration in commercial growth that rose to 17% year-over-year was surprisingly strong and contributed to a $32M top-line beat, the firm notes. This could help refute investor fears that Salesforce Life Sciences Cloud might temper growth, which has not materialized, adds Piper. The firm notes that Veeva remains one of its highest conviction large-cap GARP ideas as a specialty vertical application with a 40%-plus OM model poised to double revenue to $6B by 2030.
Wells Fargo
Stan Berenshteyn
Overweight
maintain
$285 -> $300
2025-05-29
Reason
Wells Fargo
Stan Berenshteyn
Price Target
$285 -> $300
2025-05-29
maintain
Overweight
Reason
Wells Fargo analyst Stan Berenshteyn raised the firm's price target on Veeva to $300 from $285 and keeps an Overweight rating on the shares. The firm notes it expected the Q1 beat, but says the full-year guidance raise was "pleasantly surprising," as management cited no momentum change to financials or sales pipeline despite clients facing elevated macro/policy uncertainty.
Stifel
Buy
maintain
$272 -> $295
2025-05-29
Reason
Stifel
Price Target
$272 -> $295
2025-05-29
maintain
Buy
Reason
Stifel raised the firm's price target on Veeva to $295 from $272 and keeps a Buy rating on the shares following what the firm says was an "unexpectedly strong start" to the year. FY26 revenue growth guidance was raised from 11% to 13%, which implies decelerating growth as year progresses and "feels conservative despite management commentary" to the contrary, the analyst tells investors.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Veeva Systems Inc (VEEV.N) is 37.27, compared to its 5-year average forward P/E of 50.98. For a more detailed relative valuation and DCF analysis to assess Veeva Systems Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
50.98
Current PE
37.27
Overvalued PE
73.05
Undervalued PE
28.91
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
36.63
Current EV/EBITDA
29.00
Overvalued EV/EBITDA
51.42
Undervalued EV/EBITDA
21.84
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
15.79
Current PS
14.77
Overvalued PS
21.37
Undervalued PS
10.21
Financials
Annual
Quarterly
FY2026Q1
YoY :
+16.71%
759.04M
Total Revenue
FY2026Q1
YoY :
+45.93%
233.73M
Operating Profit
FY2026Q1
YoY :
+41.15%
228.19M
Net Income after Tax
FY2026Q1
YoY :
+39.80%
1.37
EPS - Diluted
FY2026Q1
YoY :
+15.39%
871.25M
Free Cash Flow
FY2026Q1
YoY :
+5.24%
77.10
Gross Profit Margin - %
FY2026Q1
YoY :
-9.14%
41.53
FCF Margin - %
FY2026Q1
YoY :
+20.92%
30.06
Net Margin - %
FY2026Q1
YoY :
+11.76%
14.07
ROIC
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 231.96% over the last month.
Sold
0-3
Months
899.7K
USD
6
3-6
Months
1.3M
USD
3
6-9
Months
390.1K
USD
1
0-12
Months
740.9K
USD
2
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 169.12% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
639.0K
Volume
10
6-9
Months
237.4K
Volume
7
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
6
3.5M
Volume
Months
6-9
17
2.0M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress areSelling! The selling amount has increased100%over the last month.
Sold
0-3
Months
16.0K
USD
2
3-6
Months
8.0K
USD
1
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
2
16.0K
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areSelling! The selling amount has increased 231.96% over the last month.
Sold
0-3
Months
899.7K
USD
6
3-6
Months
1.3M
USD
3
6-9
Months
390.1K
USD
1
0-12
Months
740.9K
USD
2
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
VEEV News & Events
Events Timeline
2025-07-21 (ET)
2025-07-21
13:02:30
Six of top 20 pharma companies committed to Veeva Vault CRM, says Barclays
2025-07-21
11:18:36
Oppenheimer sees Merck agreement as strong endorsement for Veeva's Vault CRM
2025-07-21
10:03:51
Veeva announces Merck committed to Veeva Vault CRM
Sign Up For More Events
Sign Up For More Events
News
7.0
07-30PRnewswireUne enquête révèle que les medtechs manquent de confiance dans la qualité des données réglementaires
7.0
07-30PRnewswireFalta de confianza de las empresas de tecnología médica en la calidad de los datos regulatorios
7.0
07-30PRnewswireUmfrage zeigt: Medizintechnikern fehlt das Vertrauen in die Qualität regulatorischer Daten
Sign Up For More News
People Also Watch
HUM
Humana Inc
261.470
USD
+12.40%
MLM
Martin Marietta Materials Inc
575.320
USD
-0.79%
LEN
Lennar Corp
112.370
USD
-3.01%
DXCM
Dexcom Inc
89.060
USD
-0.32%
ED
Consolidated Edison Inc
102.590
USD
+0.34%
IMO
Imperial Oil Ltd
84.300
USD
-1.61%
SLF
Sun Life Financial Inc
61.190
USD
-1.37%
ETR
Entergy Corp
89.290
USD
+1.19%
WAB
Westinghouse Air Brake Technologies Corp
190.640
USD
-1.11%
RJF
Raymond James Financial Inc
169.460
USD
+0.86%
FAQ
What is Veeva Systems Inc (VEEV) stock price today?
The current price of VEEV is 286.9 USD — it has decreased -0.11 % in the last trading day.
What is Veeva Systems Inc (VEEV)'s business?
What is the price predicton of VEEV Stock?
What is Veeva Systems Inc (VEEV)'s revenue for the last quarter?
What is Veeva Systems Inc (VEEV)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Veeva Systems Inc (VEEV)'s fundamentals?
How many employees does Veeva Systems Inc (VEEV). have?